IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lynx1 Capital Management LP

Q1 2022 Holdings

Filed 2022-05-16 | 14 holdings | $107.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Merus N VCOMN5749R100$23.6K893,52721.9%
Bellus Health Inc New(BLU)COM NEW07987C204$19.6K2,851,58818.2%
Alpine Immune Sciences Inc(NVLSEUR)COM02083G100$13.3K1,484,69312.4%
Pardes Biosciences IncCOM69945Q105$11.9K1,642,83411.0%
Travere Therapeutics Inc(TVTX)COM89422G107$10.6K411,6809.9%
Kinnate Biopharma IncCOM49705R105$7.8K692,5087.2%
Immunogen Inc(IMGNEUR)COM45253H101$7.3K1,543,2596.8%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$4.3K1,388,5054.0%
Theseus Pharmaceuticals IncCOM88369M101$4.1K356,8273.8%
Pieris Pharmaceuticals IncCOM720795103$3.4K1,136,3193.2%
Aerovate Therapeutics IncCOM008064107$1.2K66,9771.1%
Passage BIO IncCOM702712100$327105,5040.3%
Otonomy IncCOM68906L105$7230,0000.1%
Elevation Oncology IncCOM28623U101$2510,0000.0%